M&A Deal Summary

Chemistree Technology Acquires The Physician’s Choice CBD

On April 29, 2019, Chemistree Technology acquired consumer products company The Physician’s Choice CBD

Acquisition Highlights
  • This is Chemistree Technology’s 1st transaction in the Consumer Products sector.
  • This is Chemistree Technology’s 1st transaction in the United States.
  • This is Chemistree Technology’s 1st transaction in Arizona.

M&A Deal Summary
Date 2019-04-29
Target The Physician’s Choice CBD
Sector Consumer Products
Buyer(s) Chemistree Technology
Deal Type Add-on Acquisition

Target

The Physician’s Choice CBD

Scottsdale, Arizona, United States
The Physician’s Choice CBD LLC is dedicated to research, development, and utilization of the highest quality of hemp-derived cannabidiol (CBD) combined with well-studied and effective supplements specific to help regulate and support various symptoms.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Chemistree Technology

Vancouver, British Columbia, Canada
Category Company
Sector Business Services
DESCRIPTION

Chemistree Technology, Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry. The Company's corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management's decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution, and retail facilities.

DEAL STATS #
Overall 1 of 1
Sector (Consumer Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Arizona) 1 of 1
Country (United States) 1 of 1
Year (2019) 1 of 1
Mergr

Product

Company

Legal